These patients may not benefit from mammalian targetof rapamycin (mTOR) inhibitors.4 One study found TFE3 rearrangements in 23% of all diagnosed PEComa cases.8 Our case represents one such nonconventional PEComa. This evidence concerns the gene TFE3 and neoplasm with perivascular epithelioid cell differentiation.